Revere Partners
Revere Partners is a New York-based venture capital firm that invests exclusively in early-stage oral health startups (Seed to Series B), while also offering corporate deal-flow services, an SPV syndication platform (Revere+), and modular fund administration (Revere+ for Pros).
- Company typePrivate
- Founded2019
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Revere Partners does
Revere Partners is a New York-based venture capital firm founded in 2019 by Dr. Jeremy Krell and David Arena, operating as the first independent VC fund exclusively dedicated to oral health. The firm invests across Seed to Series B stages in dental startups spanning software, fintech, biotech, medtech, specialty products, and clinical services, with 40+ portfolio companies and claimed diligence on over 1,000 dental startups through a proprietary pipeline database. Beyond the core VC fund, Revere operates three additional business lines: Corporate Services (curated deal flow, market intelligence, and M&A support for industry corporates), Revere+ (an SPV platform enabling accredited investors to back single companies), and Revere+ for Pros (modular fund administration, compliance, IR, and portfolio success services for external fund managers). The firm also operates RISE Health as an inclusion-driven oral health subsidiary fund, and is currently raising Fund III with a stated $200M AUM target.
The firm's value proposition rests on domain specialization supported by a network of senior strategic advisors drawn from the ADA, Delta Dental, Colgate, Henry Schein, and leading dental schools. Revenue is generated through traditional VC management fees (2–3% of AUM), performance-based carried interest, corporate services fees, and platform fees from Revere+ and Revere+ for Pros. Operating geographies span North America, Europe, Asia, and South America, with deal flow sourced through DSOs, manufacturers, insurers, distributors, labs, professional associations, and a startup application portal. The competitive positioning emphasizes category-of-one status in oral health venture investing, with distribution reach claimed across over 100,000 dental practices worldwide through ecosystem connections.
Revere Partners firmographics
Firmographics- Name
- Revere Partners
- Legal name
- Revere Partners
- Website
- https://reverepartnersvc.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Revere Partners is a New York-based venture capital firm that invests exclusively in early-stage oral health startups (Seed to Series B), while also offering corporate deal-flow services, an SPV syndication platform (Revere+), and modular fund administration (Revere+ for Pros).
- Ownership category
- akta.pro rank
Revere Partners industry classification
Industry- Product category
- Venture Capital Management
- NAICS
- Open-End Investment Funds (525910)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Joint Venture CVC / Consortium Funds (Multi-corporate) (FSANAHAE)
Keywords
Where Revere Partners is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Revere Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Venture Capital Management Fees: Traditional VC fund management fees (2-3% of AUM) charged to limited partners for fund administration and investment management services
- Carried Interest (Carry): Performance-based carried interest on successful portfolio company exits, typically 20% of profits above the hurdle rate
- Corporate Services Fees: Customized deal flow, market intelligence, commercial partnerships, investment and M&A support services for corporate partners
- Revere+ SPV Platform: Platform fees from single-company SPVs allowing startups to raise capital directly from accredited investors
- Revere+ for Pros Fund Admin: Fund administration services including fund formation, compliance, reporting, portal management for fund managers across verticals
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | VC Fund Investment |
| Other | Multi-year contract | Corporate Services |
| Other | Multi-year contract | Revere+ for Pros |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Revere Partners product offering
Product offeringCore offering
Revere Partners is a venture capital firm that invests in early-stage oral health companies from seed through Series B. Beyond fund management, the firm offers three adjacent services: a Corporate Services program that connects portfolio companies with strategic partners across the oral health ecosystem, a Revere+ SPV platform that enables accredited investors to co-invest alongside the fund through special purpose vehicles, and Revere+ for Pros, a white-label fund administration offering provided to other venture firms.
Product overview
Revere Partners is a venture capital firm offering a suite of investment and fund administration services for the oral health industry. The core offering includes a Venture Capital Fund (Seed to Series B investments in oral health technology), Corporate Services (deal flow and market intelligence for partners), Revere+ (SPV platform for single-company capital raises), and Revere+ for Pros (fund administration and investment services). These services are designed to support founders, corporate partners, and investors throughout the oral health investment lifecycle.
Differentiator
Problem solved
Functional benefit
Brands
- Revere+: Platform for single companies to raise capital directly from accredited investors through special purpose vehicles (SPVs)
- Revere+ for Pros (RFP)
Products and services
- Revere Partners Venture Fund Core venture capital fund that invests equity capital in early-stage oral health startups spanning seed through Series B stages, for founders building in dentistry and adjacent oral health categories.
- Revere Corporate Services Program offering oral health startups access to strategic corporate partnerships, distribution channels, and enterprise relationships, designed for portfolio companies seeking commercial traction beyond capital.
- Revere+ SPV Platform Platform that allows accredited investors and family offices to co-invest in Revere Partners portfolio companies through special purpose vehicles, providing access to category-specialized deal flow.
- Revere+ for Pros White-label fund administration service for other venture and private equity fund managers, providing back-office operations support on a subscription basis.
Companies that use Revere Partners
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles4 records
Revere Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Revere Partners partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered event partner and partnership.
- Dental VIP Summitevent partnerJeremy Krell serves as co-chair of Dental VIP Summit addressing dental-medical integration, DSO evolution, and capital formation in oral health
- ToothappspartnershipPartnership announced January 2023 to facilitate dental innovation through connected platforms
- Seattle Study ClubpartnershipPartnership announced November 2022 to advance dental education and clinical excellence
- Workman School of Dental MedicinepartnershipPartnership with dental school to support education and innovation in oral health
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
Revere Partners competitors and assessment
Company assessmentDirect peers
- Flare Capital Partners: Flare Capital is a healthcare-focused venture capital firm investing in early-stage and growth-stage health technology companies, often at Seed to Series B. It is comparable to Revere as a sector-specialized healthcare VC with a similar stage focus, fund structure, and emphasis on industry-specific networks and thesis-driven investing.
- CareCapital: CareCapital is a dental-focused venture capital and growth equity firm, primarily active in Asia, that invests across the oral health value chain. It is the most direct comparable to Revere Partners given its exclusive dental vertical focus, multi-stage investment approach, and similar fund structure targeting oral health startups and growth-stage companies.
Broad incumbents
- Andreessen Horowitz (a16z Bio): Andreessen Horowitz is one of the largest and most active venture capital firms, with a dedicated bio/healthcare fund (a16z Bio) investing across healthcare, biotech, and digital health. It is a broad incumbent that competes for healthcare Seed-to-Series B opportunities overlapping with Revere's investment stages, though with a far broader sector mandate and much larger fund sizes.
- Vivo Capital: Vivo Capital is a healthcare-focused investment firm investing across venture, growth, and buyout stages in biotech, medtech, and healthcare services. It is a broad incumbent with a healthcare-only mandate that overlaps with Revere's medical-device and digital health oral health investments, though at typically larger check sizes and later stages.
- Welsh, Carson, Anderson & Stowe: Welsh, Carson, Anderson & Stowe is a private equity firm with a dedicated healthcare focus, investing across healthcare services, medical devices, and healthcare technology. It is a broad incumbent comparable to Revere's healthcare investment profile, with deeper healthcare specialization than generalist VCs and a stage range that overlaps with growth-stage oral health opportunities.
- Optum Ventures: Optum Ventures is the corporate venture capital arm of Optum/UnitedHealth Group, investing broadly in healthcare innovation including digital health, AI, and care delivery. It is a broad incumbent comparable to Revere's healthcare VC peer set, with much larger AUM and a broader healthcare mandate that overlaps with Revere's oral health investments.
- Khosla Ventures: Khosla Ventures is a large venture capital firm investing across technology and healthcare, including substantial health tech and biotech exposure. It is a broad incumbent that competes at the Seed-to-Series B stages in healthcare and digital health, with far greater AUM and a generalist thesis that occasionally overlaps with Revere's portfolio.
- ARCH Venture Partners: ARCH Venture Partners is a leading life sciences and technology venture capital firm with deep healthcare and biotech expertise across all stages. It is a broad incumbent comparable to Revere's healthcare VC profile, with larger fund sizes, a longer track record of healthcare exits, and a broader biotech/medtech mandate that overlaps with Revere's medical-device oral health investments.
- Sequoia Capital: Sequoia Capital is one of the largest and most established venture capital firms, with broad healthcare and consumer health exposure. It is a broad incumbent that competes for high-quality Seed-to-Series B healthcare and consumer health opportunities, with far greater AUM, brand recognition, and global reach than Revere.
- General Catalyst: General Catalyst is a major venture capital firm with a dedicated healthcare practice (Health Assurance) and broad technology investments. It is a broad incumbent that competes for Seed-to-Series B healthcare and digital health deals, with much larger fund sizes and a broader mandate that occasionally overlaps with Revere's oral health investment thesis.
Market position
Strengths6 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Revere Partners social profiles
Digital presenceRevere Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Revere Partners leadership team
Management profileNumber of profiles
Profiles2 records
Revere Partners subsidiaries and ownership
Company hierarchySubsidiaries1 record
Revere Partners funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Revere Partners M&A and investment
M&A and investmentM&A
Investments14 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Revere Partners
What does Revere Partners do?
Revere Partners is a venture capital firm that invests in early-stage oral health companies from seed through Series B. Beyond fund management, the firm offers three adjacent services: a Corporate Services program that connects portfolio companies with strategic partners across the oral health ecosystem, a Revere+ SPV platform that enables accredited investors to co-invest alongside the fund through special purpose vehicles, and Revere+ for Pros, a white-label fund administration offering provided to other venture firms.
Is Revere Partners a public or private company?
Revere Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Revere Partners founded?
Revere Partners was founded in 2019. It employs 11 to 50 people.
Where is Revere Partners based?
Revere Partners is headquartered in New York, United States, in the North America region.
How does Revere Partners make money?
Five revenue lines are on record. Venture Capital Management Fees are the primary driver. The others are carried Interest (Carry), corporate Services Fees, revere+ SPV Platform and revere+ for Pros Fund Admin.
Who are Revere Partners's main competitors?
Direct peers on record are Flare Capital Partners and CareCapital. Broad incumbents are Andreessen Horowitz (a16z Bio), Vivo Capital, Welsh, Carson, Anderson & Stowe, Optum Ventures, Khosla Ventures, ARCH Venture Partners, Sequoia Capital and General Catalyst.
Does Revere Partners have an API?
No public API is recorded for Revere Partners.
What industry is Revere Partners in?
Revere Partners's product category is Venture Capital Management. Its primary akta.pro industry code is FSANAHAE, Joint Venture CVC / Consortium Funds (Multi-corporate). Its NAICS code is 525910 and its SIC code is 8742.